Preventive nasal administration of flagellin restores antimicrobial effect of gentamicin and protects against a multidrug-resistant strain of Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy · 02.05.2024 · 68 (5)
DOI: 10.1128/aac.01361-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 02.05.2024. Verfasst von Ana Raquel Maia und 7 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Gentamicins, Flagellin, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Union's Horizon 2020 research and innovation programme.
Abstract (Originalsprache)
The increasing prevalence of multidrug-resistant Pseudomonas aeruginosa (PA) is a significant concern for chronic respiratory disease exacerbations. Host-directed drugs, such as flagellin, an agonist of toll-like receptor 5 (TLR5), have emerged as a promising solution. In this study, we evaluated the prophylactic intranasal administration of flagellin against a multidrug-resistant strain of PA (PA MDR ) in mice and assessed the possible synergy with the antibiotic gentamicin (GNT). The results indicated that flagellin treatment before infection decreased bacterial load in the lungs, likely due to an increase in neutrophil recruitment, and reduced signs of inflammation, including proinflammatory cytokines. The combination of flagellin and GNT showed a synergistic effect, decreasing even more the bacterial load and increasing mice survival rates, in comparison to mice pre-treated only with flagellin. These findings suggest that preventive nasal administration of flagellin could restore the effect of GNT against MDR strains of PA, paving the way for the use of flagellin in vulnerable patients with chronic respiratory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.
- Université de Tours, Faculté de Médecine, Tours, France.
- Université Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR8204 - CIIL - Center for Infection and Immunity of Lille, Lille, France.
ORCID-Profile: Adeline Cezard, Jean-Claude Sirard, Mustapha Si-Tahar, Virginie Hervé
Förderung
- European Union's Horizon 2020 research and innovation programme
Zitieren
APA
Maia, A. R., Cezard, A., Fouquenet, D., Vasseur, V., Briard, B., Sirard, J. C., Si-Tahar, M., & Hervé, V. (2024). Preventive nasal administration of flagellin restores antimicrobial effect of gentamicin and protects against a multidrug-resistant strain of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 68(5). https://doi.org/10.1128/aac.01361-23
Vancouver
Maia AR, Cezard A, Fouquenet D, Vasseur V, Briard B, Sirard JC, et al. Preventive nasal administration of flagellin restores antimicrobial effect of gentamicin and protects against a multidrug-resistant strain of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 2024;68(5). doi:10.1128/aac.01361-23
BibTeX
@article{Maia2024,
author = {Maia, Ana Raquel and Cezard, Adeline and Fouquenet, Delphine and Vasseur, Virginie and Briard, Benoit and Sirard, Jean-Claude and Si-Tahar, Mustapha and Hervé, Virginie},
title = {Preventive nasal administration of flagellin restores antimicrobial effect of gentamicin and protects against a multidrug-resistant strain of Pseudomonas aeruginosa},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
volume = {68},
number = {5},
doi = {10.1128/aac.01361-23}
}
EUVIMED